OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q2 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $907,000 | -33.3% | 146,752 | 0.0% | 0.07% | -36.4% |
| Q2 2017 | $1,360,000 | -0.1% | 146,752 | 0.0% | 0.11% | -2.7% |
| Q1 2017 | $1,362,000 | -34.0% | 146,752 | -40.5% | 0.11% | -40.8% |
| Q4 2016 | $2,065,000 | -4.5% | 246,752 | -21.6% | 0.19% | -4.0% |
| Q3 2016 | $2,162,000 | +98.7% | 314,752 | +43.2% | 0.20% | +53.1% |
| Q2 2016 | $1,088,000 | -48.8% | 219,752 | 0.0% | 0.13% | -56.2% |
| Q1 2016 | $2,123,000 | +64.1% | 219,752 | +138.9% | 0.30% | +47.0% |
| Q3 2015 | $1,294,000 | +11.8% | 92,000 | +67.3% | 0.20% | +12.8% |
| Q2 2015 | $1,157,000 | -49.9% | 55,000 | 0.0% | 0.18% | -44.1% |
| Q1 2015 | $2,309,000 | – | 55,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
| Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
| DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
| Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
| GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
| Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
| Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
| Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
| Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
| Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |